Related Experiment Video
Updated: Jan 21, 2026
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
The critical role of RasGRP4 in the growth of diffuse large B cell lymphoma
Lin Zhu1, Chunyan Xia2, Lin Wu3
1Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University, No. 241 West Huaihai Road, Shanghai, 200030, China.
Background:
This study aimed to confirm that blocking RasGRP4 can effectively slow down the growth of DLBCL both in vitro and in vivo and ascertain the role of RasGRP4 in the prognosis of DLBCL clinically.
Methods:
RasGRP4 expression levels were examined in benign tissues and lymphomas. In order to verify somatic mutation in RasGRP4 gene, cDNA sequencing was performed in DLBCL patients. RasGRP4-dependent cell proliferation, mitochondrial membrane potential, oxidative stress levels and signaling pathway changes were measured by knockdown of RasGRP4. Tumor growth was monitored in xenografted lymphoma model. Clinical data were collected to confirm the role of RasGRP4 in DLBCL.
Results:
RasGRP4 expression was significantly elevated in DLBCL while no somatic mutations were detected of this gene in DLBCL patients. Decreased RasGRP4 significantly inhibited cell proliferation by simultaneously reducing mitosis and promoting apoptosis and increased the oxidative stress levels. Mechanistically, reduced expression of RasGRP4 decreased ERK while increased JNK expression in SUDHL-4 cells. Knockdown of RasGRP4 also significantly inhibited tumor formation in vivo. Furthermore, RasGRP4 expression levels were significantly higher in patients with larger DLBCL lesions (P = 0.0004), high-risk international prognostic index score groups (P = 0.0042), and its expression was positively correlated with maximum standardized uptake value in DLBCL (P = 0.0004).
Conclusions:
These findings indicate the oncogenic role of RasGRP4 in DLBCL, suggesting it as a prognostic biomarker and potential therapeutic target in DLBCL.
Insights
Blocking RasGRP4 significantly inhibits Diffuse Large B-cell Lymphoma (DLBCL) growth by reducing proliferation and increasing apoptosis. RasGRP4 shows potential as a prognostic biomarker and therapeutic target for DLBCL.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Diffuse Large B-cell Lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
- Identifying novel therapeutic targets and prognostic biomarkers for DLBCL is crucial.
Purpose of the Study:
- To investigate the role of Ras-related guanylylcylase activating protein 4 (RasGRP4) in DLBCL pathogenesis.
- To evaluate RasGRP4 as a potential therapeutic target and prognostic indicator in DLBCL.
Main Methods:
- Examined RasGRP4 expression in DLBCL tissues and benign controls.
- Performed cDNA sequencing to detect somatic mutations in RasGRP4.
- Assessed the impact of RasGRP4 knockdown on DLBCL cell proliferation, apoptosis, oxidative stress, and signaling pathways (ERK, JNK).
- Evaluated tumor growth in a xenograft lymphoma model.
- Correlated RasGRP4 expression with clinical parameters of DLBCL patients.
Main Results:
- RasGRP4 expression was significantly elevated in DLBCL, with no detected somatic mutations.
- RasGRP4 knockdown inhibited cell proliferation, reduced mitosis, promoted apoptosis, and increased oxidative stress.
- Mechanistically, RasGRP4 knockdown decreased ERK and increased JNK signaling.
- Inhibition of RasGRP4 significantly reduced tumor formation in vivo.
- Higher RasGRP4 expression correlated with larger DLBCL lesions, high-risk prognostic scores, and increased metabolic activity (SUVmax).
Conclusions:
- RasGRP4 plays an oncogenic role in DLBCL.
- RasGRP4 serves as a potential prognostic biomarker for DLBCL.
- RasGRP4 represents a promising therapeutic target for DLBCL treatment.
Related Concept Videos
01:28Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
01:12Diffusion
01:21Diffusion
01:16Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
01:31Critical Values
01:18Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....